By vgreene, 27 September, 2017 Intraocular pressure nbsp nbsp There s limited evidence L that cannabinoids are ineffective for improving IOP in glaucoma per NAS 1 nbsp nbsp AGS2 notes that marijuana can temporarily lower IOP but side effects short duration of action and lack of evidenc
By vgreene, 27 September, 2017 IBS sx. Evidence for effectiveness of dronabinol is insufficient/none [I/N], per NAS1
By vgreene, 27 September, 2017 Anorexia nervosa. Evidence for effectiveness of cannabinoids is insufficient/none [I/N], per NAS1
By vgreene, 27 September, 2017 HIV/AIDS-assoc low appetite & wt loss: Evidence for effectiveness of cannabis & oral cannabinoids for ↑ appetite ↓ wt loss is limited [L], per NAS1
By vgreene, 27 September, 2017 CA-assoc anorexia/cachexia syndrome. Evidence for effectiveness on cannabinoids is insufficient/none [I/N], per NAS.1 NCI2 notes no published studies on inhaled cannabis for appetite in CA pts
By vgreene, 27 September, 2017 Chemo-induced N/V antiemesis. Evidence for effectiveness of oral cannabinoids is conclusive or substantial [C] [S], per NAS.1 NCI2 notes a meta-analysis of controlled clinical trials supports a beneficial effect of cannabinoids (dronabinol, nabilone) on c
